Lichen China Ltd. Reverse Stock Split & Name Change Effective March 3

Ticker: LICN · Form: 6-K · Filed: Feb 28, 2025 · CIK: 1876766

Lichen China LTD 6-K Filing Summary
FieldDetail
CompanyLichen China LTD (LICN)
Form Type6-K
Filed DateFeb 28, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: reverse-stock-split, name-change, corporate-action

TL;DR

Lichen China is doing a 1-for-10 reverse split and changing its name to Lichen International, effective March 3rd.

AI Summary

Lichen China Limited announced on February 27, 2025, that its previously disclosed 1-for-10 reverse stock split and name change to "Lichen International Limited" will become effective on March 3, 2025. This action aims to adjust the company's issued share capital and enhance its market perception.

Why It Matters

This reverse stock split and name change could signal a strategic move by Lichen China to improve its stock price and potentially attract new investors or meet exchange listing requirements.

Risk Assessment

Risk Level: medium — Reverse stock splits can sometimes be perceived negatively by the market, potentially indicating underlying issues or a struggle to maintain a minimum stock price.

Key Numbers

Key Players & Entities

FAQ

What is the new name of the company?

The company will change its name to Lichen International Limited.

When will the reverse stock split and name change become effective?

The changes will become effective on March 3, 2025.

What is the ratio of the reverse stock split?

The reverse stock split ratio is 1-for-10.

What is the purpose of the reverse stock split and name change?

The purpose is to adjust the company's issued share capital and potentially enhance its market perception.

What exhibit contains the announcement details?

Exhibit 99.1 contains the press release detailing the announcement.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on February 28, 2025 regarding Lichen China Ltd (LICN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing